Rankings
▼
Calendar
SNDX FY 2017 Earnings — Syndax Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
SNDX
Syndax Pharmaceuticals, Inc.
$2B
FY 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
+72.8% YoY
Gross Profit
$2M
100.0% margin
Operating Income
-$62M
-2939.0% margin
Net Income
-$61M
-2884.3% margin
EPS (Diluted)
$-2.90
Cash Flow
Operating Cash Flow
-$47M
Free Cash Flow
-$47M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$137M
Total Liabilities
$33M
Stockholders' Equity
$104M
Cash & Equivalents
$35M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$1M
+72.8%
Gross Profit
$2M
$1M
+72.8%
Operating Income
-$62M
-$44M
-41.6%
Net Income
-$61M
-$44M
-36.7%
← Q4 2016
All Quarters
Q1 2017 →